Situation regarding Covid-19 for BOPSS 2021 meeting

Given the escalating situation we have now decided to postpone the Oxford Meeting until 2021. Further details will be sent to members and delegates. Thank you for your support and we hope you can attend next year. It will be an exceptional meeting, in all senses of the word. Updated 20/3/2020 more info for delegates here

Eyelid Surgery for Thyroid Eye Disease

Through BOPSS, Rebecca Ford and her team completed a UK survey on the provision of eyelid surgery for patients with thyroid eye disease (TED). The conclusions were presented at the 2019 BOPSS meeting. Provision for this surgery varies depending on the individual CCGs. Before approval is obtained for eyelid surgery, however, most patients will have had to apply for individual funding requirements (IFR), secured prior approval (PA) or met the criteria for a planned procedure with a threshold (PPPwT). These approvals [...]

Retrobulbar Hyaluronidase to reverse CRAO following injection of facial fillers

Retrobulbar Hyaluronidase to reverse CRAO following injection of facial fillers. The consensus is both in review and animal studies1-8 that, as yet, there is not conclusive evidence to support this treatment. Only a limited number of case reports and theoretical proposals have been recorded in support of the technique9,10. Thus, it is our advice that ophthalmology units do not need to be equipped to provide an emergency retrobulbar hyaluronidase service. Best practice dictates that all practitioners should be aware of [...]

Mohs Micrographic Surgery (MMS)

The Mohs Service Guidance and Standards (updated January 2020) have now been published and are available to download using the link below. Mohs Micrographic Surgery Services Guidance and Standards

Call for Members of the Scientific Committee representing oculoplastics

A joint post between the College and BOPSS has been announced on The Royal College of Ophthalmologists website Role Member of the Scientific Committee representing oculoplastics Summary Use your expertise to influence the scientific standards and practice of ophthalmology. Join the College’s Scientific Committee to promote and advise on scientific research and innovation, support educational and academic meetings and promote the use of evidence-based guidelines in ophthalmology. For more information please see the job description here. Applications should be submitted via the website application [...]

BOPSS ‘state of TED care’ survey and recommendations

As the BOPSS National TED Lead, I have been working closely with TEAMeD to implement TEAMeD-5. The findings of the BOPSS ‘state of TED care’ survey and recommendations on delivering a sustainable TED service nationally have now been published These recommendations have been endorsed by TEAMeD, BOPSS, the Royal College of Ophthalmologists, the Royal College of Physicians, Society for Endocrinology (SOE) , the British Thyroid Foundation (BTF) and the British and Irish Orthoptic Society (BIOS) The paper is open access thanks to [...]

thumbnail of bapras-bopss-mohs-guidelines

Mohs Micrographic Surgery (MMS) UK surgical standards & service guidance

Introduction In 2019 the British Association of Plastic, Reconstructive & Aesthetic Surgeons (BAPRAS) and the British Oculoplastic Surgery Society (BOPSS) formed a multidisciplinary working party to set these UK Mohs Micrographic Surgery standards and guidance, supported by an advisory panel of experts from a range of relevant specialties and interests. Published standards or guidelines for Mohs Micrographic Surgery (MMS) currently exist both in the UK and internationally, but these do not adequately encompass the needs and requirements of all MMS practitioners [...]

thumbnail of SNB-Consensus-Final-1

Melanoma consensus statement

Introduction Sentinel node biopsy (SNB) has been at the forefront of the surgical staging of melanoma patients for the past 15 years. The high accuracy of this prognostic staging procedure is now recognised in all international guidelines for melanoma. However during this period there have been a number of important changes in the management of melanoma, many occurring within the past five years. The outcomes of five recent randomised Phase 3 trials have established the role of adjuvant targeted therapy [...]